NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword por Shaima'a Hamarsheh, Shaima'a Hamarsheh, Robert Zeiser, Robert Zeiser, Robert Zeiser, Robert Zeiser

Obter o texto integral

Immune modulatory effects of oncogenic KRAS in cancer por Shaima’a Hamarsheh, Olaf Groß, Tilman Brummer, Robert Zeiser

Obter o texto integral

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation por Shaima’a Hamarsheh, Lena Osswald, Benedikt S. Saller, Susanne Unger, Donatella De Feo, Janaki Manoja Vinnakota, Martina Konantz, Franziska M. Uhl, Heiko Becker, Michael Lübbert, Khalid Shoumariyeh, Christoph Schürch, Geoffroy Andrieux, Nils Venhoff, Annette Schmitt-Graeff, Sandra Duquesne, Dietmar Pfeifer, Matthew A. Cooper, Claudia Lengerke, Melanie Boerries, Justus Duyster, Charlotte M. Niemeyer, Miriam Erlacher, Bruce R. Blazar, Burkard Becher, Olaf Groß, Tilman Brummer, Robert Zeiser

Obter o texto integral